 Connection
Lisa Maier to Pulmonary Diffusing Capacity
This is a "connection" page, showing publications Lisa Maier has written about Pulmonary Diffusing Capacity.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.687 |
|
|
|
-
Yadav R, Lippitt WL, Chae KJ, Rieck J, Carlson NE, Liao SY, Mroz MM, Barkes B, Humphries SM, Oh A, Hwang HJ, Parker K, Fuentealba AI, McLaren T, Marrocchio C, Fingerlin TE, Culver DA, Lynch DA, Maier LA. Demographic and Physiological Differences Between Fibrotic and Nonfibrotic CT Subtypes of Sarcoidosis. Chest. 2026 Jul; 170(1):137-148.
Score: 0.236
-
Benn BS, Lippitt WL, Cortopassi I, Balasubramani GK, Mortani Barbosa EJ, Drake WP, Herzog E, Gibson K, Chen ES, Koth LL, Fuhrman C, Lynch DA, Kaminski N, Wisniewski SR, Carlson NE, Maier LA. Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic Impairment. Chest. 2024 Nov; 166(5):1093-1107.
Score: 0.209
-
Mroz MM, Ferguson JH, Faino AV, Mayer A, Strand M, Maier LA. Effect of inhaled corticosteroids on lung function in chronic beryllium disease. Respir Med. 2018 May; 138S:S14-S19.
Score: 0.135
-
Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, Maier LA. Efficacy of mycophenolate mofetil in sarcoidosis. Respir Med. 2014 Nov; 108(11):1663-9.
Score: 0.107
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|